Early research (Phase 1)Study completedNCT06363292
What this trial is testing
Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects
Who this might be right for
Ophthalmological Agent ToxicityBacterial Conjunctivitis
Laboratorios Sophia S.A de C.V. 37